Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Seubert, J M ^a   Xu, F ^b   Graves, J P ^a   Collins, J B ^a   Sieber, S O ^a   Paules, R S ^a   Kroetz, D L ^b   Zeldin, D C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arachidonic acid; Elastase; Hypertension; Real time polymerase chain reaction; Soluble epoxide hydrolase

Indexed keywords

COMPLEMENTARY DNA; ELASTASE; EPOXIDE HYDROLASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ELA1 GENE; ENVIRONMENTAL FACTOR; EPHX2 GENE; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEREDITY; HYPERTENSION; KIDNEY FUNCTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RAT STRAIN; SPECIES DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE;

EID: 23944501007     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00354.2004     Document Type: Article

References (54)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, and Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999.
2. Briones AM, Gonzalez JM, Somoza B, Giraldo J, Daly CJ, Vila E, Gonzalez MC, McGrath JC, and Arribas SM. Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling. J Physiol 552: 185-195, 2003.
3. Bushel PR, Hamadeh H, Bennett L, Sieber S, Martin K, Nuwaysir EF, Johnson K, Reynolds K, Paules RS, and Afshari CA. MAPS: a microarray project system for gene expression experiment information and data validation. Bioinformatics 17: 564-565, 2001.
4. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
5. Chen Y, Kamat V, Dougherty ER, Bittner ML, Meltzer PS, and Trent JM. Ratio statistics of gene expression levels and applications to microarray data analysis. Bioinformatics 18: 1207-1215, 2002.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, and Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003.
7. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, and Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14: 457-460, 1996.
8. Dickhout JG and Lee RM. Structural and functional analysis of small arteries from young spontaneously hypertensive rats. Hypertension 29: 781-789, 1997.
9. Eisen MB, Spellman PT, Brown PO, and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
10. Franklin SS, Gustin Wt Wong ND, Larson MG, Weber MA, Kannel WB, and Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96: 308-315, 1997.
11. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, and Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37: 869-874, 2001.
12. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, and Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103: 1245-1249, 2001.
13. Frostegard J, Wu R, Gillis-Haegerstrand C, Lemne C, and de Faire U. Antibodies to endothelial cells in borderline hypertension. Circulation 98: 1092-1098, 1998.
14. Giummelly P, Lartaud-Idjouadiene I, Marque V, Niederhoffer N, Chillon JM, Capdeville-Atkinson C, and Atkinson J. Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats. Hypertension 34: 207-211, 1999.
15. Guidi E, Menghetti D, Milani S, Montagnino G, Palazzi P, and Bianchi G. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol 7: 1131-1138, 1996.
16. Hecker M, Bara AT, Bauersachs J, and Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 481: 407-414, 1994.
17. Imig JD, Zhao X, Capdevila JH, Morisseau C, and Hammock BD. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39: 690-694, 2002.
18. Iwatsuki K, Iijima F, and Chiba S. Reduction of blood pressure and vascular collagen in the spontaneously hypertensive rat by elastase. Arch Int Pharmacodyn Ther 263: 63-73, 1983.
19. Kaergel E, Muller DN, Honeck H, Theuer J, Shagdarsuren E, Mullally A, Luft FC, and Schunck WH. P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage. Hypertension 40: 273-279, 2002.
20. Komamura K, Shirotani-Ikejima H, Tatsumi R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K, and Miyata T. Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray. Cardiovasc Drugs Ther 17: 303-310, 2003.
21. Laping NJ, Olson BA, and Zhu Y. Identification of a novel nuclear guanosine triphosphate-binding protein differentially expressed in renal disease. J Am Soc Nephrol 12: 883-890, 2001.
22. Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar M, and Camilleri JP. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 63: 227-239, 1988.
23. Lifton RP, Gharavi AG, and Geller DS. Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001.
24. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method. Methods 25: 402-408, 2001.
25. Ma J, Graves J, Bradbury JA, Zhao Y, Swope DL, King L, Qu W, Clark J, Myers P, Walker V, Lindzey J, Korach KS, and Zeldin DC. Regulation of mouse renal CYP2J5 expression by sex hormones. Mol Pharmacol 65: 730-743, 2004.
26. Marque V, Kieffer P, Atkinson J, and Lartaud-Idjouadiene I. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. Hypertension 34: 415-422, 1999.
27. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, Charchar FJ, Brosnan MJ, and Dominiczak AF. Microarray analysis of rat chromosome 2 congenic strains. Hypertension 41: 847-853, 2003.
28. McBride MW, Charchar FJ, Graham D, Miller WH, Strahorn P, Carr FJ, and Dominiczak AF. Functional genomics in rodent models of hypertension. J Physiol 554: 56-63, 2004.
29. Mueller PW, Hall WD, Caudill SP, MacNeil ML, and Arepally A. An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens 8: 1072-1082, 1995.
30. Muller DN, Theuer J, Shagdarsuren E, Kaergel E, Honeck H, Park JK, Markovic M, Barbosa-Sicard E, Dechend R, Wellner M, Kirsch T, Fiebeler A, Rothe M, Haller H, Luft FC, and Schunck WH. A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol 164: 521-532, 2004.
31. Okamoto K and Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27: 282-293, 1963.
32. Okuda T, Sumiya T, Iwai N, and Miyata T. Difference of gene expression profiles in spontaneous hypertensive rats and Wistar-Kyoto rats from two sources. Biochem Biophys Res Commun 296: 537-543, 2002.
33. Okuda T, Sumiya T, Mizutani K, Tago N, Miyata T, Tanabe T, Kato H, Katsuya T, Higaki J, Ogihara T, Tsujita Y, Iwai N, and Muzutani K. Analyses of differential gene expression in genetic hypertensive rats by microarray. Hypertens Res 25: 249-255, 2002.
34. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, and Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 15: 426-444, 2002.
35. Pravenec M, Landa V, Zidek V, Musilova A, Kren V, Kazdova L, Aitman TJ, Glazier AM, Ibrahimi A, Abumrad NA, Qi N, Wang JM, St Lezin EM, and Kurtz TW. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 27: 156-158, 2001.
36. Pravenec M, Zidek V, Simakova M, Kren V, Krenova D, Horky K, Jachymova M, Mikova B, Kazdova L, Aitman TJ, Churchill PC, Webb RC, Hingarh NH, Yang Y, Wang JM, Lezin EM, and Kurtz TW. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest 103: 1651-1657, 1999.
37. Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, Enayetallah AE, Zeldin DC, and Grant DF. Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64: 482-490, 2003.
38. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev 80: 135-172, 2000.
39. Rettig R, Folberth CG, Stauss H, Kopf D, Waldherr R, Baldauf G, and Unger T. Hypertension in rats induced by renal grafts from renovascular hypertensive donors. Hypertension 15: 429-435, 1990.
40. Roman RJ. Altered pressure-natriuresis relationship in young spontaneously hypertensive rats. Hypertension 9: III130-III136, 1987.
41. Safar ME and Laurent P. Pulse pressure and arterial stiffness in rats: comparison with humans. Am J Physiol Heart Circ Physiol 285: H1363-H1369, 2003.
42. Safar ME, Levy BI, and Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107: 2864-2869, 2003.
43. Safar ME, London GM, and Plante GE. Arterial stiffness and kidney function. Hypertension 43: 163-168, 2004.
44. Sellar GC, Steel DM, Zafiropoulos A, Seery LT, and Whitehead AS. Characterization, expression and evolution of mouse beta 2-glycoprotein 1 (apolipoprotein H). Biochem Biophys Res Commun 200: 1521-1528, 1994.
45. Sinal CJ, Miyata M, Tonkin M, Nagata K, Bend JR, and Gonzalez FJ. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275: 40504-40510, 2000.
46. Trippodo NC and Frohlich ED. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 48: 309-319, 1981.
47. van Gorp AW, Schenau DS, Hoeks AP, Boudier HA, de Mey JG, and Reneman RS. In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am J Physiol Heart Circ Physiol 278: H1241-H1247, 2000.
48. Vaziri ND, Wang XQ, Oveisi F, and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.
49. Watanabe M, Honda M, and Hatano M. Effect of elastase on blood pressure and urinary excretions of prostaglandins and catecholamines in the spontaneously hypertensive rat (SHR). Prostaglandins Leukot Essent Fatty Acids 34: 181-186, 1988.
50. Wixtrom RN, Silva MH, and Hammock BD. Cytosolic epoxide hydrolase in human placenta. Placenta 9: 559-563, 1988.
51. Wong P, Pineault J, Lakins J, Taillefer D, Leger J, Wang C, and Tenniswood M. Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 268: 5021-5031, 1993.
52. Wong P, Taillefer D, Lakins J, Pineault J, Chader G, and Tenniswood M. Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 221: 917-925, 1994.
53. Yu Z, Davis BB, Morisseau C, Hammock BD, Olson JL, Kroetz DL, and Weiss RH. Vascular localization of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol 286: F720-F726, 2004.
54. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, and Kroetz DL. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxycicosatrienoic acids. Circ Res 87: 992-998, 2000.